PIAS3 and adrenal cortex carcinoma: PIAS3 acted as an adverse effect in ACC (p = 0.0037, Fig. 3J), KIRP (p = 0.040, Fig. 3K), LGG (p = 0.012, Fig. 3L) and MESO (p = 0.0024, Fig. 3N).